By futureTEKnow | Editorial Team
Imagine a world where surgeons can see through blood during an operation—where the “invisible” becomes visible, and critical tissue is never obscured by bleeding. That’s the promise behind HemoLucence, the latest innovation from Ocutrx Technologies, and it’s poised to set a new standard for surgical visualization.
HemoLucence is a real-time 3D visualization tool developed by Ocutrx’s Genius Labs. Its claim to fame: the ability to render blood virtually transparent during surgery. This is achieved through a combination of RT3D (real-time 3D) digital volumetric reconstruction and advanced de-scattering algorithms. By analyzing how light interacts with blood and tissue, the system reconstructs detailed 3D images of what lies beneath, even when those structures would normally be hidden by blood.
Advanced Algorithms: HemoLucence collects images from multiple angles, distinguishing between light absorbed by blood and light scattered by red blood cells.
3D Rendering: The technology reconstructs tissue structure and texture in three dimensions, providing surgeons with a clear, detailed view—even in the midst of bleeding.
Surgical Integration: The system is paired with the OR-Bot 3D Surgical Microscope, which is heading into clinical trials in 2025 or 2026.
Bleeding is a constant challenge in surgery, often obscuring the very tissues surgeons need to see. Traditional visualization tools can’t always keep up, especially in complex or high-stakes procedures. HemoLucence aims to change that dynamic:
“The ability to render blood ‘transparent’ now makes the unseen, in the heat of surgical battle, seen, creating another layer of safety and confidence for surgeons that traditional visual aids can’t provide,”
says Dr. Leonel Hunt, Ocutrx Medical Advisor and attending surgeon at Cedars-Sinai
Neurosurgeon Dr. Robert Louis adds that this breakthrough “helps overcome those challenges and is a significant step forward in making surgery safer and more efficient”
At its core, HemoLucence leverages mathematics and physics to analyze light’s behavior through blood-filled areas. This approach isn’t just theoretical; Ocutrx reports visualization accuracy down to about three millimeters—a level of detail that could make a real difference in the operating room.
Ocutrx isn’t stopping at medicine. The company’s recent acquisition of Spectrum Advanced Manufacturing Technologies signals ambitions across aerospace, spaceflight, and defense. With 42 issued patents and more than 50 in the pipeline, Ocutrx is clearly betting big on RT3D visualization as a transformative technology.
While HemoLucence is still awaiting clinical trials, its potential is hard to ignore. Real-time 3D visualization has already shown clear benefits in surgical planning and intraoperative decision-making, improving confidence and outcomes for surgeons. If HemoLucence delivers on its promise, it could become a must-have tool in operating rooms worldwide.
The ability to “see through blood” during surgery isn’t science fiction anymore. With HemoLucence, Ocutrx is pushing the boundaries of what’s possible in surgical visualization—offering a glimpse into a future where no detail is ever out of sight
Founded in 2018, futureTEKnow is a global database dedicated to capturing the world’s most innovative companies utilizing emerging technologies across five key sectors: Artificial Intelligence (AI), immersive technologies (MR, AR, VR), blockchain, robotics, and the space industry. Initially launched as a social media platform to share technology news, futureTEKnow quickly evolved into a comprehensive resource hub, spotlighting the latest advancements and groundbreaking startups shaping the future of tech.
Campfire has secured $35M to launch an AI-first ERP platform, streamlining finance operations for high-growth companies with rapid, multi-model deployment.
Remark secures $16M Series A to humanize AI in online shopping, using real expert knowledge to deliver a more personal, effective e-commerce experience.
Genesis AI emerges from stealth with $105M to build a universal robotics foundation model, aiming to revolutionize general-purpose physical AI.
AI is transforming workplace decisions, with managers using it to determine promotions and firings. Here’s what you need to know about the risks and tools involved.
Zango AI launches from stealth with $4.8M funding, introducing AI agents that automate and simplify financial compliance for banks and fintechs.
Jeff Bezos-backed $88M methane-tracking satellite has gone silent after losing contact in June, impacting climate data.
MIT researchers use generative AI to optimize robot design, enabling higher jumps and safer landings. Learn how diffusion models are transforming robotics.
Pearson and Google are partnering to introduce AI-powered learning tools in classrooms, aiming to personalize education and enhance teaching with adaptive technology.
Daphne-AT is an advanced AI assistant designed to help astronauts independently manage emergencies in deep space, providing real-time analysis and actionable solutions when mission control is out of reach.
Xona Space Systems lands $75M to launch LEO satellites, promising next-gen GPS accuracy and reliability for autonomous vehicles, robotics, and critical infrastructure.
Former Oculus execs reunite to launch Sesame, a smart glasses startup blending AI-powered assistants and all-day wearability. Backed by $57M, Sesame aims to set a new standard in wearable tech.
Alibaba’s GRAPE AI model detects stomach cancer from CT scans with higher accuracy than radiologists, offering a breakthrough in non-invasive early detection.
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2025 All Rights Reserved.
